EGENE
Live / Registered — Registered (as of 01 Aug 2023)
What this means for you
Registered since 01 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97132863
- Registration number
- 7124080
- Mark type
- Stylized text
- Filed
- 18 Nov 2021
- Published for opposition
- 16 May 2023
- Registered
- 01 Aug 2023
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use, namely, nucleic acid sequences, genes and proteins; therapeutic DNA and RNA products, namely, nucleic acid sequences, genes and proteins for medical and veterinary purposes; vaccines; all for expression of proteins and none being mutation detection reagents, genome editing reagents, or polynucleotide assembly reagents
- Class 009 — Scientific and electric apparatus: Scientific apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; medical laboratory research instrument in the nature of desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; bio-chips for scientific, research or industrial purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using polymerase chain reaction (PCR); apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; computer hardware, recorded computer software, downloadable computer software, and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science
- Class 010 — Medical apparatus: Apparatus and instruments for DNA, RNA, gene and protein synthesis for medical and veterinary purposes
Owner
- NUCLERA LTD, CAMBRIDGE, GB
- NUCLERA LTD, CAMBRIDGE, GB
- Nuclera Nucleics Limited, Cambridge, GB
- Nuclera Nucleics Limited, Cambridge, GB
Prosecution history
- 01 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 May 2023 — PUBLISHED FOR OPPOSITION
- 26 Apr 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Apr 2023 — EXAMINER'S AMENDMENT ENTERED
- 13 Apr 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Apr 2023 — EXAMINERS AMENDMENT E-MAILED
- 13 Apr 2023 — EXAMINERS AMENDMENT -WRITTEN
- 11 Apr 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Apr 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Apr 2023 — ASSIGNED TO LIE
- 30 Mar 2023 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED